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Wheezing is a lower respiratory tract symptom induced by various viral respiratory
infections. Epidemiological studies have revealed the phenotypes of wheezing in early
childhood which have different risk factors for the development of asthma among school
age children. The major viral species causing wheezing in children include respiratory
syncytial virus, rhinovirus, human metapneumovirus and inﬂuenza viruses. It has been
shown that the impact on the development of asthma is different between those virus
species. Moreover, recent studies have also focused on the interaction between virus
infection and other risk factors in the development of asthma, such as genetic factors or
allergic sensitization. In this review, we summarize the previous ﬁndings and discuss how
clinicians can effectively intervene in these viral infections to prevent the development of
asthma.
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INTRODUCTION
Wheezing is a lower respiratory tract symptom induced by var-
ious viral respiratory infections. It is in common in children,
with approximately one-third of the children having at least one
wheezing episode by age nine. However, about 1 to 2% of affected
infants need to be hospitalized due to respiratory distress. More-
over, although the condition is transient in the majority of cases,
some children develop recurrent wheezing and are diagnosed to
have asthma when they reach school age. In those children, the
virus-induced wheezing in early childhoodmay be associated with
the subsequent development of recurrent wheezing and/or asthma
in connection to the pathology of asthma, including chronic air-
way inﬂammation, thus leading to airwayhyperresponsiveness and
airway remodeling.
Epidemiological studies are therefore considered to be impor-
tant for clarifying which populations are at risk for developing
virus-induced wheezing accompanied with other severe symp-
toms, recurrent wheezing and especially asthma. Moreover, recent
studies have also focused on the interaction between virus infec-
tion and other risk factors for the development of asthma, such as
genetic factors or allergic sensitization.
In this review, we summarize the previous ﬁndings and discuss
how clinicians can effectively intervene in these viral infections to
prevent the development of asthma.
PHENOTYPES OF VIRUS-INDUCED WHEEZING
Birth cohort studies have been conducted to clarify the natural
history of wheezing in early childhood and to assess the risk fac-
tors for the development of wheezing and subsequent asthma.
The ﬁrst large prospective study focusing on the wheezing his-
tory was performed by the Tucson Children’s Respiratory Study
group (Halonen et al., 1999; Sherrill et al., 1999; Stein et al., 1999;
Taussig et al., 2003;Morgan et al., 2005). They followed 828 infants
until the age of 6 years and identiﬁed four different patterns of
wheezing in early childhood (neverwheeze, transient earlywheeze,
late-onset wheeze, and persistent wheeze) on the basis of clini-
cal observations. The “never wheeze” phenotype (51.5% of the
cohort) was deﬁned as children with no episodes of wheezing
during the ﬁrst 6 years of the life. The “transient early wheeze”
phenotype (19.9% of the cohort) was deﬁned as children having
at least one lower respiratory tract illness with wheezing dur-
ing the ﬁrst 3 years of the life, but no wheezing at 6 years of
age. The children with this phenotype had a diminished air-
way function both before the age of 1 year and at the age of
6 years, were more likely than the other children to have moth-
ers who smoked but not mothers with asthma, and did not have
elevated serum IgE levels or skin-test reactivity. The “late-onset
wheeze” phenotype (15.0% of the cohort) was deﬁned as chil-
dren having no wheezing before the age of the 3 years, but having
wheezing at 6 years of age. The “persistent wheeze” phenotype
(13.7% of the cohort) was deﬁned as children having wheezing
both before 3 years of age and at 6 years of age. The children
of this phenotype were more likely than the “never wheeze” chil-
dren to have mothers with a history of asthma, to have elevated
serum IgE levels and normal lung function in the ﬁrst year of
life, and to have elevated serum IgE levels and diminished airway
function at 6 years of age. Interestingly, these phenotypes have
been shown to be associated with different risk factors for the
number of encountered viral infections in early childhood (Kusel
et al., 2007) and the development of asthma (Taussig et al., 2003;
Stein and Martinez, 2004).
Birth cohort studies from Europe using latent class analy-
sis identiﬁed more complicated wheezing phenotypes, including
an intermediate-onset wheezing phenotype. A population-based
birth cohort study of 6265 children in the United Kingdom (the
ALSPAC study) identiﬁed six wheezing phenotypes in childhood,
from birth to age 7 years, and demonstrated that these pheno-
types differed in the atopy prevalence and lung function levels
at 7–8 years of age (Henderson et al., 2008). Another multicenter
birth cohort study of 2810 children in theNetherlands (the PIAMA
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study) also identiﬁed ﬁve wheezing phenotypes in childhood from
birth to age 8 years. Interestingly, the wheezing phenotypes iden-
tiﬁed by the two birth cohort studies were comparable (Savenije
et al., 2011).
VIRAL SPECIES CAUSING WHEEZING
The major viral species causing wheezing in children include
respiratory syncytial virus (RSV), rhinovirus (HRV), human
metapneumovirus (hMPV) and inﬂuenza viruses.
RSV
Respiratory syncytial virus is a medium-sized negative-stranded
RNAvirus of the familyParamyxoviridae, which causes respiratory
infections mainly in children. Interestingly, the clinical symptoms
of RSV infection in infancy and early childhood are extremely
variable. Most infants experience an RSV infection before 3 years
of age (Ruuskanen and Ogra, 1993), normally escaping with only
upper respiratory diseases, whereas approximately 1–2% of them
require hospitalization because of severe RSV bronchiolitis (Green
et al., 1989; Stretton et al., 1992). This is particularly common
in those who are premature or who have chronic lung disease
or congenital heart disease. Recently, a humanized monoclonal
antibody designed to provide passive immunity against an epitope
in the A antigenic site of the F protein of RSV has been widely
used for the prophylaxis of severe RSV lower respiratory infection
in those children.
HRV
Rhinovirus is a small-sized positive-strandRNAvirus of the family
Picornaviridae, which is well known as the predominant cause of
the common cold. Because of the development of PCR techniques,
it has been recognized that HRVs cause not only upper respiratory
infections, but also lower respiratory infections or asthma exacer-
bation. HRVs consist of over 100 types classiﬁed into one of three
species (A, B, and C) according to the phylogenetic sequence cri-
teria. HRV C (HRV-C) is a recently classiﬁed group and has been
shown to be associated with severe asthma attacksmore frequently
than other groups of HRV. The prevalence of HRV-associated
wheezing increases by age, and it is signiﬁcantly more common
in children with recurrent wheezing episodes than in ﬁrst-time
wheezers in age categories of <24 and <36 months (Jartti et al.,
2009).
HMPV
The hMPV is a medium-sized negative-stranded RNA virus of
the family Paramyxoviridae, which was recently discovered (van
den Hoogen et al., 2001), the clinical course of which resembles
RSV infection. Similar to RSV, it has been reported that hMPV
infection was associated with wheezing among children younger
than 3 years, especially during the winter, while hMPV was not
signiﬁcantly associated with wheezing requiring hospitalization
among children 3 years of age and older (Williams et al., 2005).
INFLUENZA VIRUSES
Inﬂuenza viruses are a medium-sized negative-stranded RNA
virus of the family of Orthomyxoviridae. Inﬂuenza viruses cause
severe lower respiratory tract complications, such as bronchitis or
pneumonia. In addition, inﬂuenza is signiﬁcantly associated with
wheezing during the winter among children younger than 3 years
of age although the detection percentage of the inﬂuenza virus is
lower than that of RSV (Heymann et al., 2004).
RISK FACTORS FOR THE DEVELOPMENT OF VIRUS-INDUCED
WHEEZING
BEHAVIORAL OR ENVIRONMENTAL FACTORS
In the Tucson study, it was reported that breast-feeding at early
infancy for at least 1 month was associated with lower rates
of virus-induced wheezing during the ﬁrst 4 months of the life
(Wright et al., 1989). However, the results of the subsequent stud-
ies have been conﬂicting. Ameta-analysis study ﬁnally showed that
there was no association between any or exclusive breast feeding
and wheezing illness (Brew et al., 2011).
Infants exposed to more children at home or day care experi-
encedmore frequent wheezing when they were 2 years old, but less
frequent wheezing from years eight through year thirteen. There-
fore, although exposure to children at home or in day care during
infancy increased wheezing in early life, it appears to be protec-
tive against the development of frequent wheezing in school age
children (Ball et al., 2000).
HOST IMMUNOLOGICAL FEATURES
Interferon (IFN) secretion is important in the clearance of viral
pathogens. Therefore, IFN deﬁciency has been supposed to lead to
lower respiratory viral infections. There are three types of inter-
ferons: Type I (IFN-α/β), Type II (IFN-γ) and Type III (IFN-λ). It
was shown that low IFN-γ production in cord bloods (Copenhaver
et al., 2004) or PBMCs in the ﬁrst year of life (Stern et al., 2007)
was a risk factor for wheezing during childhood, in addition to a
risk factor for the development of asthma and allergies (Tang et al.,
1994). It has recently been clariﬁed that the deﬁciency of IFN pro-
duction is related to atopy. It was reported that allergic asthmatic
children had an impaired HRV-induced IFN-α and IFN-λ1 pro-
duction that correlatedwith an increasedFcεRI expressiononplas-
macytoid dendritic cells in PBMCs, which were reduced by FcεRI
cross-linking (Durrani et al., 2012). In addition, it was reported
that bronchial epithelial cells from asthmatic individuals produced
less IFN-β in response to HRV, leading to impaired apoptosis
and increased HRV replication (Wark et al., 2005). Interestingly,
it was revealed that allergic sensitization precedes HRV-induced
wheezing, but the converse is not true (Jackson et al., 2012). The
results of that study suggested that allergic sensitization can lead
to more severe HRV-induced lower respiratory illnesses, which is
considered to be a risk factor for the subsequent development of
asthma.
GENETIC FACTORS
There have been many genetic risk factors reported to be associ-
ated with the development of RSV bronchiolitis. Two large scale
genetic association studies were performed using a candidate gene
approach (Janssen et al., 2007; Siezen et al., 2009). They analyzed
384 single-nucleotide polymorphisms (SNPs) in 220 candidate
genes involved in the airway mucosal responses, innate immunity,
chemotaxis, adaptive immunity, and allergic asthma. They found
that SNPs in genes of the innate immune responses (the transcrip-
tional regulator Jun, alpha interferon, IFN-α, nitric oxide synthase
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and the vitamin D receptor) are important for determining the
susceptibility to RSV bronchiolitis in term children. As RSV is
recognized by Toll-like receptor (TLR) 4, SNPs in the genes of
molecules related to TLR4 signaling have also been studied (Tal
et al., 2004; Inoue et al., 2007).
In contrast, the genetic factors related to the development of
HRV-inducedwheezing are lesswell known (Helminen et al., 2008;
Caliskan et al., 2013). However, the 17q21 variants, which were
found to be related to childhood-onset asthma in a genomewide
association study (Moffatt et al., 2007), were associated with HRV
wheezing illnesses in early life, but not with RSVwheezing illnesses
(Caliskan et al., 2013).
ASSOCIATION BETWEEN VIRUS-INDUCED WHEEZING AND
THE DEVELOPMENT OF ASTHMA, AND EFFECTIVE TYPES OF
INTERVENTION TO PREVENT THE SUBSEQUENT
DEVELOPMENT OF ASTHMA
It is still unclear whether lower respiratory viral infections are
causal factors, or instead serve as indicators, of a predisposition to
asthma. Moreover, recent studies have indicated that the impact
on the development of subsequent recurrent wheezing or asthma
is different between virus species.
It was reported that infant birth approximately 4months before
the winter virus peak, which is the peak of bronchiolitis hos-
pitalizations for that winter season, carried the highest risk for
the development of asthma, thus suggesting that a lower res-
piratory infection with winter viruses, including RSV, in early
childhood may be an important factor in the development of
asthma (Wu et al., 2008). In a birth cohort study, Sigurs et al.
(2010) followed 47 children aged <1 year hospitalized with RSV
lower respiratory infection (RSV group) and 93 age- and gender-
matched controls (Control group) for 18 years. They found that
the RSV group had an increased prevalence of asthma/recurrent
wheezing, clinical allergy and sensitization to perennial allergens,
compared to the Control group (Sigurs et al., 2010). Meanwhile,
it was shown that RSV prophylaxis using Palivizumab, a human-
ized monoclonal antibody against the RSV fusion protein that
prevents severe RSV lower respiratory infection, in non-atopic
children decreased the relative risk of recurrent wheezing by
80%, but did not have any effect in infants with an atopic
family history (Simoes et al., 2010). These results suggest that
RSV predisposes to recurrent wheezing via an atopy-independent
mechanism.
Rhinovirus has been implicated as an important pathogen in
asthma pathogenesis due to the improvement of PCR for HRV
detection. In the Childhood Origins of ASThma (COAST) cohort,
HRV in nasal lavage samples were evaluated by PCR. They found
that, by age 3 years, wheezing in those with HRV-positive sam-
ples (OR, 25.6) was more strongly associated with asthma at age
6 years than aeroallergen sensitization (OR, 3.4; Jackson et al.,
2008). As IFN deﬁciency is related to both atopy and the suscep-
tibility to HRV infection, the inhalation of IFN by HRV-infected
children with risk factors for asthma might thus help to prevent
the development of asthma.
Recently, pandemic H1N1 inﬂuenza virus has been reported to
increase the risk of lower respiratory tract complications includ-
ing asthma attack, pneumonia, and atelectasis even in atopic
children without any history of either an asthma attack or asthma
treatment, compared to the seasonal inﬂuenza virus (Hasegawa
et al., 2011). This observation suggests that the pandemic H1N1
inﬂuenza virus may be a strong risk factor contributing to the
development or exacerbation of asthma.
LIMITATIONS OF EPIDEMIOLOGY STUDIES
The correct diagnosis of individual viral infections is necessary
for assessing which virus infection is important for the devel-
opment of wheezing or the subsequent development of asthma.
The principal diagnostic methods for respiratory viruses are virus
culture, serology, immunoﬂuorescence/antigen detection, and
nucleic acid/PCR-based tests (Tregoning and Schwarze, 2010).
Although virus culture proves that the virus detected in clin-
ically obtained samples is able to infect human cells, viral
culture is time-consuming and is not appropriate for analyzing
many samples in epidemiological studies. Viral serologic test-
ing is also time-consuming, and generally requires at least two
rounds of blood sampling, because viral serological testing can
diagnose infections by an increase of a virus-speciﬁc antibody
in the blood, which usually takes 2 weeks to develop. Most
previous epidemiological studies thus evaluated viral infections
by immunoﬂuorescence/antigen detection or nucleic acid/PCR-
based tests. Antigen detection is based on the use of virus-speciﬁc
monoclonal antibodies. There are a variety of diagnostic test kits
that use nasopharyngeal aspirate, nasopharyngeal wash or nasal
swab specimens as the test material, and detect viral antigen by
using either a conjugated enzyme or ﬂuorescence. Immunoﬂu-
orescence/antigen detection is appropriate for epidemiological
studies because it is convenient, cheap and possible to use when
handling for many samples. However, there is a limitation to the
species of target viruses. Nucleic acid tests are signiﬁcantly more
sensitive than the other methods, and are now being multiplexed,
allowing for the rapid detection of many viruses concurrently. The
PCR method has greatly increased the recovery rates of viruses
(Johnston et al., 1995; Rakes et al., 1999). However, the PCR-based
diagnosis of viruses, especially HRV, may not necessarily indicate
that the virus is causing the observed disease, because virus RNAs
can be detected by PCR for several weeks after the onset of clinical
symptoms (van Benten et al., 2003; Jartti et al., 2004; Wright et al.,
2007).
Another limitation in epidemiological studies assessing wheez-
ing/wheezes in early childhood is the difﬁculty of diagnosing these
conditions in young children based on the clinical assessment of
symptoms by both guardians and clinicians. It was reported that
the parents of children aged 4 months to 15 years and clinicians
agreedononly 45%of occasions that the patientwaswheezy or had
asthma (Cane et al., 2000), thus suggesting that epidemiological
studies using symptom records kept by guardians may sometimes
lead to a wrong conclusion. Moreover, it has been shown that
even specialists might not always correctly recognize wheezing
(Bisgaard and Bonnelykke, 2010).
FUTURE PROSPECTIVE
To our knowledge, previous epidemiological studies regarding
the association between viral infections and wheezing/asthma
did not evaluate all other risk factors for the development
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of wheezing/asthma in childhood, including behavioral fac-
tors, environmental factors, host immunological features and
genetic factors. Large birth cohort studies evaluating viral infec-
tions and these factors in childhood could thus better elucidate
the impact of viral infections on the development of wheez-
ing/asthma. However, epidemiological studies only reveal an
association, but not a causal relationship between some viral infec-
tions and the development of wheezing or asthma. Therefore, in
the future, intervention trials with preventative intervention or
therapies on a speciﬁc virus would be needed to clearly iden-
tify when and how clinicians should intervene in such viral
infections to thereby prevent the development of wheezing or
asthma.
CONCLUSION
Virus-induced wheezing is not only a burden in early childhood,
but also may be one of causes or signs of childhood asthma.
Therefore, clarifying the risk factors for virus-induced wheez-
ing in epidemiological studies can and have provided clues about
the pathogenesis of asthma. Further studies are needed to clarify
which virus(es) in which population should be the major target of
early intervention for preventing the subsequent development of
asthma.
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